Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05406895 · ClinicalTrials.gov registry record · NA
Use of CBCT to Improve Inferior Alveolar Nerve Block Success
A NA study, sponsored by Louisiana State University Health Sciences Center in New Orleans.
- Completed
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT05406895: Completed NA study, sponsored by Louisiana State University Health Sciences Center in New Orleans.
NCT05406895 is a NA study that has completed, run by Louisiana State University Health Sciences Center in New Orleans. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05406895, a NA study, has completed, sponsored by Louisiana State University Health Sciences Center in New Orleans.
- COMPLETED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The study looks to compare the success rate of lower jaw anesthesia injection (inferior alveolar nerve) that is guided by pre-treatment 3D dental scan (CBCT) versus standard injection technique.
Primary Outcome
Numbness of tongue, numbness of lingual tissue
Interventions
- DRUG 2% Lidocaine with 1:100,000 epinephrine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2022-05-25 |
| Est. Completion | 2024-03-30 |
| Phase | NA |
What the finished NCT05406895 record still lists
NCT05406895 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which 2% Lidocaine with 1:100,000 epinephrine is the first listed.
NCT05406895 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05406895 about?
NCT05406895 is a clinical study titled "Use of CBCT to Improve Inferior Alveolar Nerve Block Success". The study looks to compare the success rate of lower jaw anesthesia injection (inferior alveolar nerve) that is guided by pre-treatment 3D dental scan (CBCT) versus standard injection technique.
What is the current status of trial NCT05406895?
This trial is currently completed. It is a NA study. The enrollment target is 2 participants. The study started on 2022-05-25. Estimated completion is 2024-03-30.
What interventions are being tested in trial NCT05406895?
The interventions under investigation include: 2% Lidocaine with 1:100,000 epinephrine (DRUG).
Who is sponsoring clinical trial NCT05406895?
This trial is sponsored by Louisiana State University Health Sciences Center in New Orleans, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05406895's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI